We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Felix. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S (NVO)’s share was trading at $64.49 as of April 15th. NVO’s trailing and forward P/E were 18.76 and 15.41 respectively according to Yahoo Finance.
A scientist in a lab, researching for a breakthrough treatment for Alzheimer’s disease, diabetes nephropathy, asthma, COPD, NASH, and Type 1 Diabetes.
Novo Nordisk, a dominant player in...
